No Evidence of Association of Heterozygous NTF4 Mutations in Patients with Primary Open-Angle Glaucoma  by Liu, Yutao et al.
orders of magnitude slower than the Y-Y conversion
rate within palindromes (2.2 3 104 per base per genera-
tion4).
Our report’s otherconclusions, including the similarityof
the events-per-generation rates of crossover (translocation)
(~1 3 105; ref.1,5) and conversion (~6.6 3 106 - ~2.1 3
105; ref.1) at HSA, remain unchanged. We are gratiﬁed to
observe that, in their independent resequencing of HSA,
Cruciani and colleagues2 also discovered variants indi-
cating conversion from the X chromosome.
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To the Editor: Pasutto et al. recently reported that hetero-
zygous NTF4 (MIM 162662) sequence variants confer an
increased risk of primary open-angle glaucoma (POAG
[MIM 137760]).1 In an effort to replicate these ﬁndings,
we sequenced the complete NTF4 coding region in a large
dataset of European ancestry. The research was reviewed
and approved by the Institutional Review Board of
Duke University Medical Center (Durham, NC) and was
in accordance with the tenets of the Declaration of Hel-
sinki. Our dataset contained 443 POAG cases and 533
controls. Enrollment criteria for unrelated POAG cases
included (1) age of onset greater than 30 years; (2) glau-
comatous optic neuropathy affecting both eyes; and (3)
glaucomatous visual ﬁeld loss affecting at least one eye.
Intraocular pressure (IOP) was not an enrollment crite-
rion. Eighteen POAG cases with normal IOP were
included in our dataset. Exclusion criteria included the
presence of any secondary form of glaucoma, including
exfoliation syndrome, or a history of ocular trauma.
The criteria for unrelated control subjects were (1) IOP
less than 21 mmHg; (2) no evidence of glaucomatous
optic neuropathy; and (3) normal visual ﬁeld by either
automated perimetry or frequency doubling test (FDT).
All clinical examination records for cases and controlswere reviewed by a glaucoma subspecialist (RRA). The
mean age of onset for POAG cases was 57.6 5 14.2 yr,
and the mean age of examination for controls was
64.7 5 9.3 yr.
We extracted DNA from peripheral blood by standard
methods. We designed primers to avoid ampliﬁcation
of the NTF4-like pseudogene (AC008687.5) on chromo-
some 19. We performed DNA sequencing on a 3730
DNA analyzer from Applied Biosystems by using Sanger
sequencing of genomic PCR products from the NTF4
coding exons. All DNA samples were sequenced success-
fully in both directions. Sequences were analyzed with
Sequencher 4.8 software by at least two people indepen-
dently. Each of the identiﬁed variants was also conﬁrmed
by a second independent PCR reaction and sequencing
analysis.
We identiﬁed ﬁve POAG cases and 12 controls with non-
synonymous coding changes in the NTF4 gene (Table 1).
The overall frequency of coding changes (5/443 versus
12/533) was not signiﬁcantly different between cases and
controls. The most frequent sequence variants were A88V
(six subjects) and R206W (three subjects). Although
Pasutto et al. reported these variants as risk alleles, we
observed a higher frequency of these variants in controls
than cases (the difference was not signiﬁcantly different
according to Fisher’s exact test). The A88V variant was
found in one case and ﬁve controls, and the R206W
variant was found in one case and two controls. We iden-
tiﬁed seven novel coding variants, including S29X, S89N,
R90C, R114G, R133H, R140C, and T207I, in the NTF4
gene. None of these variants was observed at a signiﬁcantly2, 2010
95
Table 1. NTF4 Sequence Variants Identified in 443 POAG Patients and 533 Controls
Nucleotide Alteration Amino Acid Change POAG Age at Onset (yrs) Control Age at Exam (yrs) Reported Previously
c.263C > T A88V 1 73 5 67a Yes
c.616C > T R206W 1 63 2 70a Yes
c.86C > A S29X 0 1 56 No
c.266G > A S89N 1 62 1 56 No
c.268C > T R90C 0 1 56 No
c.340C > G R114G 0 1 74 No
c.398G > A R133H 1 40 0 No
c.418C > T R140C 0 1 70 No
c.620C > T T207I 1 40 0 No
Total 5 12
a Age at exam for these two variants is the mean age at exam.different frequency in cases than in controls. We found no
instance of a single subject harboring more than one NTF4
coding variant. Interestingly, a nonsense mutation (S29X)
was found in one control but no cases. This control subject
was 56 years old and had hyperopia and presbyopia.
Because of the small number of controls with NTF4
variants, genotype-phenotype correlations cannot be
detected.
In summary, our data indicate that coding variants in
the NTF4 gene are not associated with an elevated risk
of POAG in individuals of European ancestry from the
southeastern United States. NTF4 is less conserved evolu-
tionarily than other neurotrophins (Nerve growth factor,
brain-derived neurotrophic factor (BDNF), and neurotro-
phin 3).2 NTF4-deﬁcient mice only show minor cellular
deﬁcits and develop normally to adulthood, whereas
knockouts of other neurotrophins prove lethal during
early postnatal development.3 This might partially
explain why we identiﬁed a number of different coding
variants in the NTF4 gene. Although our study popula-
tion is individuals of European ancestry, its more recent
evolutionary history is not identical to the original study
population of Pasutto et al.1 In addition, the mean age of
our cases (57.6 years) and controls (64.7 years) is lower
than that of the original study population (66.9 years
for cases and 73.9 years for controls, discovery dataset).
Our study contained only 18 (4%) normal tension glau-
coma (NTG) patients, whereas the original study had 82
(21%) NTG patients in the discovery dataset.1 The two
replication groups in the original study identiﬁed NTF4
mutations only in NTG patients, and not in POAG
patients.1 Therefore, the discrepant ﬁndings could be
due to population differences, to glaucoma subtype-
speciﬁc associations, or to associations that change with
age.4 However, our study demonstrates that heterozygous
coding changes in NTF4 do not play a signiﬁcant role in
the pathogenesis of POAG in a representative clinic-basedThe Ameri
AJHG 57population of European ancestry in the southeastern
United States.
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The URL for data presented herein is as follows:
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.
nlm.nih.gov/omim/References
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